The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.018
Bid: 0.017
Ask: 0.019
Change: 0.0005 (2.86%)
Spread: 0.002 (11.765%)
Open: 0.019
High: 0.019
Low: 0.017
Prev. Close: 0.0175
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Third tranche of shares issued to Venus Capital

18 Jul 2022 13:13

RNS Number : 8483S
Supply @ME Capital PLC
18 July 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF UNITED KINGDOM DOMESTIC LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Supply@ME Capital plc

(The "Company" or "SYME")

Share issuance and Total Voting Rights

 

Third tranche of new ordinary shares issued under equity funding facility with Venus Capital SA; new ordinary shares issued to TradeFlow directors; and to correct previous rounding issue

Capital Enhancement Plan deployment

SYME, the fintech business which provides an innovative Platform for use by manufacturing and trading companies to access Inventory Monetisation© solutions enabling their businesses to generate cashflow, today announces that it is to issue the third mandatory tranche ("Third Tranche") of new ordinary shares in the Company to Venus Capital SA ("Venus Capital"), under the key terms of the equity funding facility announced on 27 April 2022. The equity funding facility with Venus Capital forms an integral part of the Company's Capital Enhancement Plan, also announced on 27 April 2022.

The Third Tranche, comprising 1,350,000,000 new ordinary shares, will be issued at a price of 0.05 pence per share, raising gross proceeds for the Company of £675,000.

The Company will additionally issue to Venus Capital 1 warrant for every 2 ordinary shares comprised in the Third Tranche. As such, following the resolutions passed at the Company's Annual General Meeting held on 30 June 2022, the Company will issue a total of 5,585,000,000 warrants to Venus Capital in connection with the signing of the binding agreement and the issue of the first three tranches of new ordinary shares. The issue of warrants is in line with the key terms of the equity funding facility announced on 27 April 2022. The exercise price of the warrants referred to above is 0.065p with the warrants exercisable at any time up to 31 December 2025.

Additionally, with respect to the £1.95m bullet loan announced on 27 April 2022, the Company:

· has exercised its discretion to draw down £100,000 of Loan Notes in order to support its working capital needs. In this regard, the Company will continue to assess its working capital needs and may, at its own discretionary, draw down further amounts in the future;

· will issue £308,500 of Loan Notes in order to settle the over-all fees due to Venus Capital regarding the arrangement of the Capital Enhancement Plan and the three mandatory tranches of equity issues to date.

These Loan Notes are convertible into new ordinary shares with a maturity date of 31 December 2025 at a 10% p.a. interest rate.

TradeFlow acquisition related earn-out payments

The Company will issue 106,762,760 new ordinary shares to each of Tom James, Chief Executive Officer and Chief Investment Officer of TradeFlow Capital Management ("TradeFlow"), and John Collis, Chief Risk Officer and Head of Compliance at TradeFlow, who are both executive directors of SYME, in relation to settlement of post-acquisition earn out payments for the financial year ended 31 December 2021. The combined number of 213,525,520 new ordinary shares was determined by reference to a pre-determined revenue milestone, of which 80% was achieved by TradeFlow during 2021. As detailed in the Company's Annual Report and Accounts for the year ended 31 December 2021, there is an option for the Company to settle the post-acquisition earn out payments in either cash or shares and in this instance the option to settle through the issue of new ordinary shares has been chosen.

Correction of discrepancy concerning number of new ordinary shares in issue

The Company identified that a discrepancy of two ordinary share had occurred between the number reported on its share register and the number of shares in issue recorded at Companies House. This discrepancy was caused due to rounding issues and resulted in two ordinary shares being omitted from previous applications for listing. The Company is seeking to correct this discrepancy through the issue of an additional two new ordinary shares as part of the current share issue. 

Total voting rights

Applications has been made to the Financial Conduct Authority (the "FCA") and to the London Stock Exchange plc (the "London Stock Exchange") for admission of ordinary shares comprising the Third Tranche, the TradeFlow new ordinary shares and the two new ordinary shares to the standard segment of the Official List and to trading on the London Stock Exchange's main market for listed securities, respectively ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 19 July 2022.

The Company hereby notifies the market, in accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, that following the issue of the Third Tranche of new ordinary shares to Venus Capital, the issue of new ordinary shares to TradeFlow directors and to correct the previous discrepancy in the number of shares, the Company's issued share capital will consist of 42,352,865,472 ordinary shares of £0.00002 per share ("ordinary shares"), each with one vote. There are no shares held in Treasury. Therefore, the total number of voting rights in the Company is 42,352,865,472 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For the purposes of UK MAR, the person responsible for arranging release of this Announcement on behalf of SYME is Alessandro Zamboni, CEO.

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780; paul.vann@walbrookpr.com

Chanice Smith, Cicero/AMO, +44 (0)20 7947 5317; chanice.smith@cicero-group.com

Notes

Supply@ME Capital PLC and its operating subsidiaries (together the "Group") provide an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehouse goods waiting to be sold to end-customers or goods/commodities that are part of a typical import/export transaction. SYME announced in August 2021 the launch of a global Inventory Monetisation programme which will be focused on both inventory in transit monetisation and warehouse goods monetisation. This program will be focused on creditworthy companies and not those in distress or otherwise seeking to monetise illiquid inventories. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOELVLFFLDLFBBB
Date   Source Headline
3rd Oct 20222:00 pmRNSPrice Monitoring Extension
3rd Oct 202212:22 pmRNSPublication of Prospectus & Total Voting Rights
30th Sep 20224:18 pmRNSTotal Voting Rights
29th Sep 20227:00 amRNS2022 Interim Results
22nd Sep 20227:00 amRNSExercise of Warrants, Issue of Equity and TVR
14th Sep 20227:00 amRNSExercise of Warrants, Issue of Equity and TVR
13th Sep 20227:00 amRNSHolding in Company
12th Sep 20227:00 amRNSInaugural IM transaction executed
6th Sep 20222:00 pmRNSPrice Monitoring Extension
5th Sep 202211:05 amRNSSecond Price Monitoring Extn
5th Sep 202211:00 amRNSPrice Monitoring Extension
5th Sep 20227:00 amRNSIssue of Equity & Total Voting Rights
31st Aug 20227:00 amRNSIssue of Equity & Total Voting Rights
30th Aug 20227:12 amRNSHolding in Company
23rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
23rd Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 20227:00 amRNSResult of Open Offer
17th Aug 202211:05 amRNSPDMR/PCA Shareholding: Stock Loans Updates
15th Aug 20224:41 pmRNSSecond Price Monitoring Extn
15th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20224:41 pmRNSSecond Price Monitoring Extn
10th Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20227:00 amRNSFirst IM Transaction: Binding commitment signed
8th Aug 20222:00 pmRNSPrice Monitoring Extension
1st Aug 20225:15 pmRNSTotal Voting Rights
1st Aug 20228:00 amRNSHolding in Company
29th Jul 20224:41 pmRNSSecond Price Monitoring Extn
29th Jul 20224:36 pmRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSUpdate on first Inventory Monetisation Transaction
25th Jul 20227:00 amRNSDirectors/PDMR Shareholding
22nd Jul 20227:00 amRNSOpen Offer & Business Update
18th Jul 20221:13 pmRNSThird tranche of shares issued to Venus Capital
30th Jun 20224:29 pmRNSResult of AGM
28th Jun 20227:00 amRNSStrategic Alliance with VeChain Foundation
23rd Jun 20227:00 amRNSTradeflow and DP World complete first transaction
14th Jun 20227:00 amRNSNotice of AGM: CORRECTION
13th Jun 20227:00 amRNSAppointment of Independent Non-Executive Director
10th Jun 20227:00 amRNSNotice of AGM
6th Jun 20224:17 pmRNSPosting of 2021 Annual Report & Notice of AGM
6th Jun 20227:00 amRNSAppointment of new independent Non-Executive Chair
31st May 20227:00 amRNS2021 Annual Financial Report
25th May 20223:01 pmRNSTotal Voting Rights
10th May 20224:38 pmRNSSecond tranche of shares issued to Venus Capital
10th May 20227:00 amRNSSecond tranche of shares issued to Venus Capital
3rd May 20229:06 amRNSSecond Price Monitoring Extn
3rd May 20229:00 amRNSPrice Monitoring Extension
27th Apr 20222:06 pmRNSSecond Price Monitoring Extn
27th Apr 20222:00 pmRNSPrice Monitoring Extension
27th Apr 202211:05 amRNSSecond Price Monitoring Extn
27th Apr 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.